Published in Blood Weekly, September 20th, 2001
Currently, recommendations for the testing of viral safety in plasma derivatives indicates previously untreated patients (PUPs) should be used. However, a group at the University of Lund in Malmo, Sweden, has used previously treated, noninfected patients (NIPs) to test plasma derivatives, and they are claiming success.
"Several product lots can be studied in a single patient, with a study period for each lot of three months," said E....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.